Case File №
#VI-2026-0767
Pure Rawz
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Melanotan II | A Great | 4 | 8.1 | 7.4 | 9.2 | 8 May 2025 |
| Retatrutide | A Great | 4 | 8.6 | 8.1 | 9.1 | 6 May 2025 |
| Semaglutide | A Great | 4 | 8.4 | 7.9 | 9.0 | 6 May 2025 |
| Tirzepatide | B Good | 4 | 6.9 | 6.3 | 7.7 | 7 May 2025 |
| BPC-157 | C Okay | 4 | 7.1 | 4.7 | 9.5 | 5 May 2025 |
| CJC-1295 | D Poor | 4 | 4.6 | 4.0 | 5.5 | 7 May 2025 |
| Ipamorelin | D Poor | 5 | 5.0 | 3.8 | 6.3 | 5 May 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X N/A | 1 | 6.0 | 6.0 | 6.0 | 13 Jun 2025 |
| 5-amino-1MQ | X N/A | 2 | 6.7 | 6.2 | 7.1 | 24 May 2026 |
| AA Water | X N/A | 1 | 4.0 | 3.7 | 3.7 | 28 Mar 2025 |
| Adipotide | X N/A | 1 | 8.2 | 8.2 | 8.2 | 25 Apr 2025 |
| AHK-CU | X N/A | 1 | 8.0 | 8.0 | 8.0 | 8 Jul 2025 |
| Andarine (S-4) Raw | X N/A | 2 | 6.0 | 5.0 | 7.1 | 21 May 2026 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 27 Feb 2025 |
| BPC 500mcg + TB500 500mcg Blend Oral | X N/A | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| Bronchogen | X N/A | 1 | 8.3 | 8.3 | 8.3 | 14 Jan 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.7 | 4.7 | 4.7 | 9 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 |
| Enclomiphene | X N/A | 2 | 6.5 | 5.9 | 7.0 | 25 May 2026 |
| EPO | X N/A | 2 | 7.2 | 7.0 | 7.4 | 19 Jan 2026 |
| Humanin | X N/A | 2 | 6.5 | 5.2 | 7.8 | 26 Jan 2026 |
| Hyaluronic acid | X N/A | 2 | 7.2 | 6.5 | 7.9 | 25 May 2026 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X N/A | 2 | 8.6 | 7.4 | 9.7 | 23 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 6.0 | 6.0 | 6.0 | 20 Jun 2025 |
| Liraglutide | X N/A | 1 | 6.1 | 6.1 | 6.1 | 3 Jun 2025 |
| MK-677 (Ibutamoren) | X N/A | 1 | 8.7 | 8.7 | 8.7 | 9 Jun 2025 |
| MOTS-C | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| MT-1 | X N/A | 2 | 4.9 | 4.3 | 5.6 | 23 May 2026 |
| NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | X N/A | 2 | 5.2 | 5.1 | 5.4 | 19 Jan 2026 |
| Ovagen | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 6.3 | 6.3 | 6.3 | 24 Apr 2025 |
| Selank | X N/A | 1 | 7.2 | 7.2 | 7.2 | 21 May 2025 |
| Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | X N/A | 1 | 6.8 | 6.8 | 6.8 | 8 Jul 2025 |
| Test Base (No Ester) | X N/A | 2 | 7.0 | 6.9 | 7.1 | 21 May 2026 |
| Trenbolone Acetate | X N/A | 2 | 6.2 | 6.2 | 6.3 | 25 May 2026 |
| Trenbolone Enanthate | X N/A | 1 | 5.4 | 5.4 | 5.4 | 2 Jul 2025 |
| Turinabol Raw | X N/A | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 |
| Vitamin B12 10mg/ml | X N/A | 2 | 6.0 | 5.3 | 6.8 | 21 May 2026 |
| Vitamin B12 1mg/ml | X N/A | 1 | 7.0 | 7.0 | 7.0 | 2 Apr 2025 |
| Vitamin D3 20000iu/ml | X N/A | 2 | 7.4 | 7.0 | 7.8 | 26 Jan 2026 |
Exhibit II
Evidence Log
53 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | 5-amino-1MQ | 7.5 A | 2mg | 1.8mg | -10.2% | 99.55% | g2fo2b | Lab A | Public |
| 24 May 2026 | AA Water | 5.9 B | 5mg | 4.9mg | -1.7% | 98.54% | ygpipv | Lab A | Community |
| 24 May 2026 | Humanin | 5.6 B | 50mg | 49.6mg | -0.7% | 99.45% | xt7q86 | Lab G | Public |
| 24 May 2026 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 9.2 A | 100mg/ml | 95.1mg/ml | -4.9% | 99.83% | 2n0hcg | Lab C | Community |
| 24 May 2026 | Trenbolone Enanthate | 5.2 B | 300mg/ml | 351.1mg/ml | +17.0% | 95.66% | xwoeiv | Lab B | Community |
| 24 May 2026 | Proviron (Mesterolone) | 7.6 A | 50mg | 60.1mg | +20.3% | 98.53% | o8799g | Lab A | Public |
| 23 May 2026 | Enclomiphene | 7.3 A | 20mg | 24.6mg | +23.2% | 99.47% | mcnv3l | Lab G | Public |
| 21 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 7.8 A | 10g | 12.0g | +20.1% | 97.28% | 4u9gvb | Lab A | Public |
| 21 May 2026 | EPO | 6.8 A | 5mg | 4.8mg | -3.4% | 97.48% | 34xq33 | Lab D | Public |
| 21 May 2026 | 5-amino-1MQ | 4.7 C | 50mg | 52.8mg | +5.7% | 95.16% | xphf0c | Lab F | Community |
| 21 May 2026 | MK-677 (Ibutamoren) | 10.0 A | 10mg | 11.8mg | +18.3% | 96.11% | 95wcas | Lab G | Public |
| 21 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 6.5 A | 10g | 9.9g | -1.4% | 97.13% | b571m9 | Lab E | Community |
| 20 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 9.6 A | 100mg | 104.4mg | +4.4% | 97.06% | r5xvq1 | Lab E | Public |
| 20 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 6.3 A | 500g | 535.4g | +7.1% | 97.07% | 2rbyg0 | Lab C | Public |
| 20 May 2026 | Vitamin B12 1mg/ml | 6.5 A | 250mg/ml | 293.6mg/ml | +17.4% | 99.58% | tzk36d | Lab G | Public |
| 29 Jan 2026 | Adipotide | 9.7 A | 50mg | 48.9mg | -2.3% | 96.29% | 3p2f5t | Lab C | Public |
| 29 Jan 2026 | Hyaluronic acid | 6.6 A | 20mg | 20.4mg | +2.0% | 95.45% | 7x5js5 | Lab A | Public |
| 26 Jan 2026 | AHK-CU | 8.7 A | 30mg | 36.3mg | +20.9% | 96.10% | 0xeyis | Lab C | Public |
| 26 Jan 2026 | Vitamin B12 10mg/ml | 6.4 A | 300mg/ml | 317.3mg/ml | +5.8% | 95.49% | msswg5 | Lab G | Community |
| 26 Jan 2026 | Vitamin D3 20000iu/ml | 7.6 A | 200mg/ml | 230.4mg/ml | +15.2% | 99.55% | 328tqs | Lab A | Public |
| 19 Jan 2026 | Enclomiphene | 8.3 A | 100mg | 87.0mg | -13.0% | 95.07% | 0jwee9 | Lab B | Public |
| 19 Jan 2026 | Vitamin D3 20000iu/ml | 7.7 A | 250mg/ml | 308.1mg/ml | +23.2% | 97.68% | tmb97v | Lab D | Public |
| 9 Jan 2026 | Humanin | 6.0 A | 30mg | 33.1mg | +10.4% | 95.04% | p6khwi | Lab E | Community |
| 9 Jan 2026 | MT-1 | 6.3 A | 30mg | 28.5mg | -5.0% | 98.53% | 4i96i9 | Lab D | Public |
| 9 Jan 2026 | Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | 7.3 A | 300mg/ml | 345.8mg/ml | +15.3% | 96.63% | 9t8x3q | Lab C | Public |
| 9 Jan 2026 | Trenbolone Acetate | 6.0 A | 250mg/ml | 255.1mg/ml | +2.0% | 95.66% | cbvdeq | Lab E | Public |
| 7 Jan 2026 | MT-1 | 4.9 C | 30mg | 34.7mg | +15.5% | 96.33% | sl3fqr | Lab E | Public |
| 7 Jan 2026 | Ovagen | 7.3 A | 5mg | 4.6mg | -8.2% | 98.62% | 99os7i | Lab D | Public |
| 7 Jan 2026 | Test Base (No Ester) | 6.1 A | 200mg/ml | 209.6mg/ml | +4.8% | 95.23% | 4bzt7q | Lab C | Public |
| 29 Dec 2025 | Andarine (S-4) Raw | 5.0 B | 10g | 10.5g | +4.8% | 99.42% | ekrhni | Lab A | Community |
| 29 Dec 2025 | Bronchogen | 9.1 A | 2mg | 2.0mg | +1.2% | 96.41% | umuzkv | Lab E | Public |
| 29 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 C | 50mg | 55.6mg | +11.1% | 95.40% | loppm4 | Lab F | Community |
| 29 Dec 2025 | EPO | 7.4 A | 15mg | 13.4mg | -10.5% | 96.02% | 991bba | Lab A | Public |
| 29 Dec 2025 | Trenbolone Acetate | 7.7 A | 250mg/ml | 252.3mg/ml | +0.9% | 98.83% | s1jbiy | Lab E | Public |
| 12 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 C | 5mg | 4.3mg | -14.3% | 99.79% | 1956xw | Lab F | Public |
| 12 Dec 2025 | Liraglutide | 4.7 C | 2mg | 1.8mg | -7.8% | 95.97% | qscj5s | Lab E | Community |
| 12 Dec 2025 | Selank | 7.5 A | 2mg | 2.0mg | -0.7% | 98.33% | 4idy7b | Lab E | Community |
| 12 Dec 2025 | Turinabol Raw | 5.5 B | 1g | 1.0g | +2.9% | 98.05% | nhkr3h | Lab D | Community |
| 12 Dec 2025 | Vitamin B12 10mg/ml | 7.9 A | 200mg/ml | 215.6mg/ml | +7.8% | 95.67% | q70lw1 | Lab G | Public |
| 5 Dec 2025 | Hyaluronic acid | 4.9 C | 50mg | 47.1mg | -5.9% | 97.86% | qut7p2 | Lab C | Community |
| 17 Nov 2025 | Andarine (S-4) Raw | 7.0 A | 1g | 1.2g | +16.6% | 99.14% | 692vf3 | Lab C | Public |
| 17 Nov 2025 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 8.2 A | 100g | 120.8g | +20.8% | 97.79% | ldvzc0 | Lab F | Public |
| 5 Nov 2025 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 8.4 A | 250mg/ml | 252.9mg/ml | +1.2% | 95.63% | 952lkr | Lab D | Public |
| 17 Oct 2025 | Cerebrolysin | 6.9 A | 30mg | 37.4mg | +24.6% | 98.31% | fxnjif | Lab E | Community |
| 9 Oct 2025 | MOTS-C | 4.0 C | 15mg | 14.2mg | -5.5% | 95.98% | 1b0pi3 | Lab B | Public |
| 9 Oct 2025 | Test Base (No Ester) | 9.0 A | 100mg/ml | 96.4mg/ml | -3.6% | 95.52% | alt8ps | Lab D | Public |
| 3 Jun 2025 | Ipamorelin | 4.7 D | 2mg | 1.31mg | -34.5% | 98.84% | PRWZ-050 | Lab E | Public |
| 21 May 2025 | Melanotan II | 7.5 A | 10mg | 8.85mg | -11.5% | 99.64% | PRWZ-062 | Lab D | VendorInvestigator |
| 21 May 2025 | Retatrutide | 8.2 A | 5mg | 4.96mg | -0.8% | 99.08% | R5T04 | Lab D | VendorInvestigator |
| 21 May 2025 | Retatrutide | 8.1 A | 5mg | 4.68mg | -6.4% | 99.27% | R5T04 | Lab D | VendorInvestigator |
| 21 May 2025 | Melanotan II | 9.2 A | 10mg | 9.71mg | -2.9% | 99.57% | PRWZ-062 | Lab D | VendorInvestigator |
| 21 May 2025 | Semaglutide | 7.9 A | 10mg | 10.73mg | +7.3% | 99.32% | PRZ-SEMI | Lab D | VendorInvestigator |
| 21 May 2025 | Semaglutide | 8.1 A | 10mg | 10.73mg | +7.3% | 99.44% | PRZ-SEMI | Lab D | VendorInvestigator |
— END OF EVIDENCE LOG —